Clinical Trials on Primary Hyperoxaluria Type 1 in Netherlands

Total 436 results

Alnylam Pharmaceuticals

Completed

Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1

Primary Hyperoxaluria Type 1 (PH1)

France, United Kingdom, Netherlands, Israel, Germany
Dicerna Pharmaceuticals, Inc.

Completed

A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 (PHYOX2)

Kidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)

Poland, United Kingdom, New Zealand, United States, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
Dicerna Pharmaceuticals, Inc.

Terminated

A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)

Primary Hyperoxaluria Type 1

Netherlands, Germany
Alnylam Pharmaceuticals

Completed

A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1 (ILLUMINATE-A)

Primary Hyperoxaluria Type 1 (PH1)

United States, France, United Kingdom, Switzerland, Netherlands, Israel, Germany, United Arab Emirates
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Enrolling by invitation

Long Term Extension Study in Patients With Primary Hyperoxaluria (PHYOX3)

Kidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)

United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
Alnylam Pharmaceuticals

Active, not recruiting

A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 (ILLUMINATE-C)

Primary Hyperoxaluria Type 1 | Primary Hyperoxaluria

United States, Italy, France, Lebanon, Belgium, Netherlands, Israel, United Arab Emirates, Australia, Jordan, Turkey
Dicerna Pharmaceuticals, Inc.

Completed

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients (PHYOX4)

Primary Hyperoxaluria Type 3

United States, Germany, Netherlands, United Kingdom
OxThera

Completed

Phase 2/3 Oxabact Study

Primary Hyperoxaluria

United States, Germany, Netherlands
Dicerna Pharmaceuticals, Inc.

Completed

Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria

Primary Hyperoxaluria

United States, France, Germany, Netherlands, United Kingdom
Alnylam Pharmaceuticals

Completed

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

Primary Hyperoxaluria | PH1 | RNAi Therapeutic | siRNA | AGT

France, United Kingdom, Netherlands, Israel, Germany
Radboud University Medical Center
HypoResolve

Unknown

Current State of Impaired Awareness of Hypoglycaemia in People With Type 1 Diabetes

Diabetes type1

Netherlands
Leiden University Medical Center
Andaluz Health Service

Completed

"POWER2DM Evaluation Campaign" (POWER2DMEC)

Diabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes Mellitus

Netherlands, Spain
Radboud University Medical Center
European Foundation for the Study of Diabetes; Dutch Diabetes Research Foundation

Completed

The Effect of Intravenous Lactate on Brain Lactate Concentrations During Hypoglycemia

Type 1 Diabetes Mellitus With Hypoglycemia

Netherlands
Cees Tack

Not yet recruiting

Role of Adrenaline in in the Inflammatory Response in Diabetes (RAID)

Hypoglycemia | Diabetes type1 | Inflammatory Response

Netherlands
Radboud University Medical Center

Terminated

Beta Cell Imaging in T1D Patients With a Different Glycemic Control (GLP1-reg)

Type 1 Diabetes Mellitus

Netherlands
Radboud University Medical Center

Active, not recruiting

Beta Cell Imaging During and Shortly After the Honeymoon Phase of T1D (Honeymoon)

Type 1 Diabetes Mellitus

Netherlands
University Hospital, Montpellier

Completed

Hybrid Artificial Pancreas in Home Setting (AP Hybrid)

Type 1 Diabetes Mellitus | Treatement by Insulin Pump

France, Netherlands, Italy
Royal Devon and Exeter NHS Foundation Trust
King's College London; Leiden University Medical Center

Completed

Type 1 Diabetes, Immunology, Genetics & Endogenous Insulin Production (TIGI)

Type 1 Diabetes Mellitus

Netherlands, United Kingdom
UMC Utrecht

Completed

Ovarian Ageing in Type 1 Diabetes Mellitus (OVADIA)

Type 1 Diabetes Mellitus

Netherlands
Amsterdam UMC, location VUmc

Completed

Insulin Detemir Action in Cerebro (INcEREBRO)

Type 1 Diabetes

Netherlands
Radboud University Medical Center

Completed

GLP-1 Receptor Targeting in Diabetic and Healthy Individuals (GLP-1-CPOP)

Type 1 Diabetes

Netherlands
Radboud University Medical Center

Recruiting

BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation (BetaFIT)

Type 1 Diabetes

Netherlands
University of Exeter
King's College London; Benaroya Research Institute; Royal Devon and Exeter NHS...

Recruiting

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study) (EXE-T1D)

Type1 Diabetes Mellitus

Netherlands, United States, United Kingdom
Nordin Hanssen

Recruiting

Encapsulated Faecal Microbiota Transplantation to Preserve Residual Beta Cell Function in Type 1 Diabetes Mellitus (ENCAPSULATE)

Type 1 Diabetes

Netherlands
Medical Research Foundation, The Netherlands

Completed

Mobile Phone Applications and Quality of Life

Type 1 Diabetes

Netherlands
Diabeter Nederland BV

Recruiting

Evaluation of CloudCare in the Treatment of Type 1 Diabetes

Type 1 Diabetes

Netherlands
Sanofi

Completed

Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients (inRange)

Type 1 Diabetes Mellitus

Turkey, Netherlands, Brazil, United States, Germany, Hungary, United Kingdom
Inreda Diabetic B.V.

Completed

Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes (FAST 1)

Type 1 Diabetes

Netherlands
Medical Research Foundation, The Netherlands

Completed

Intraperitoneal vs Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus (IPvsSC)

Type 1 Diabetes Mellitus

Netherlands
Diabeter Nederland BV
University Medical Center Groningen

Completed

Biomarkers of Heterogeneity in Type 1 Diabetes

Type 1 Diabetes

Netherlands
Radboud University Medical Center

Terminated

Visualizing Beta Cells After Islet Transplantation (GLP1-transpl)

Type 1 Diabetes Mellitus

Netherlands, Sweden
Leiden University Medical Center

Completed

COVID-19 Glycemic Control Study

Type 1 Diabetes | Type 2 Diabetes

Netherlands
Radboud University Medical Center

Unknown

Effect of Anakinra on Insulin Sensitivity in Type 1 Diabetes Mellitus

Diabetes Mellitus

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Merck Sharp & Dohme LLC

Completed

Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery (DARE)

Hypoglycemia | Type 1 Diabetes

Netherlands
Diabeter Nederland BV

Not yet recruiting

CloudCare in the Treatment of Type 1 Diabetes in Pediatrics

Type1diabetes | Pediatric ALL

Netherlands
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; Universitair Ziekenhuis Brussel; University Hospital... and other collaborators

Completed

Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes (CRISTAL)

Type1 Diabetes

Belgium, Netherlands
Valentina Hlebec
LINNEUNIVERSITETET (LNU), Sweden (leading the consortium); EUROCARERS-ASSOCIATION... and other collaborators

Completed

A Primary Prevention Intervention for the Promotion of Psycho-social Wellbeing in Adolescent Young Carers: (ME-WE)

Mental Health Wellness 1 | Primary Prevention | Cognitive Therapy | Caregivers | Adolescent - Emotional Problem

Slovenia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
Radboud University Medical Center
European Foundation for the Study of Diabetes; Dutch Diabetes Research Foundation

Completed

The Effect of Hypoglycaemia on Brain Lactate Accumulation and Cerebral Blood Flow

Type 1 Diabetes Mellitus | Hypoglycemia Unawareness

Netherlands
Radboud University Medical Center
European Foundation for the Study of Diabetes; Dutch Diabetes Research Foundation

Completed

The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia

Type 1 Diabetes Mellitus | Hypoglycemia Unawareness

Netherlands
Bristol-Myers Squibb

Completed

Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants

HIV Infections | Human Immunodeficiency Virus Type 1 (HIV-1)

United States, Netherlands
Abbott Diabetes Care

Completed

An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT) (IMPACT)

Type 1 Diabetes Mellitus

Austria, Netherlands, Germany, Spain, Sweden
Maartje de Wit
King's College London; Juvenile Diabetes Research Foundation; University of Malaga and other collaborators

Recruiting

MyDiaMate For Remission Of Diabetes Distress In Type 1 Diabetes (MyREMEDY) (MyREMEDY)

Type 1 Diabetes | Diabetes Distress

United Kingdom, Netherlands, Germany, Spain
Amsterdam UMC, location VUmc
Eli Lilly and Company

Completed

The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA (INCONTROL)

Type 1 Diabetes Mellitus | Hypoglycemia Unawareness

Netherlands
University Medical Center Groningen
Juvenile Diabetes Research Foundation; Lexicon Pharmaceuticals

Not yet recruiting

Ambrisentan Sotagliflozin and Prevention of Renal Injury; a Randomized Evaluation (ASPIRE)

Type 1 Diabetes Mellitus With Diabetic Nephropathy

Netherlands, United States, Canada, Denmark, Finland
Radboud University Medical Center
Erasmus Medical Center; Elisabeth-TweeSteden Ziekenhuis; Onze Lieve Vrouwe Gasthuis

Completed

2000HIV Trained Innate Immunity in HIV Elite Controllers (2000HIVTrained)

HIV-1-infection

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Public Health Service of Amsterdam

Active, not recruiting

Comorbidity and Aging With HIV (agehIV)

HIV-1-infection | Ageing | Comorbidity

Netherlands
Medical Research Foundation, The Netherlands

Completed

Safety and Efficacy of RT-CGMS in Patients With Type 1 Diabetes Mellitus Treated With an Implantable Pump (IP_RT-CGMS)

Diabetes Mellitus, Type 1

Netherlands
Oslo University Hospital
Juvenile Diabetes Research Foundation; Stanford University; University of Minnesota and other collaborators

Recruiting

Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes

Type 1 Diabetes | Eating Disorders

United States, Norway, Netherlands
Medical Research Foundation, The Netherlands
Medtronic

Completed

Study to Compare Intraperitoneal Insulin to Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Netherlands
Radboud University Medical Center
AstraZeneca

Completed

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Hypoglycemia | Diabetes Mellitus, Type 1

Netherlands

Clinical Trials on Primary Hyperoxaluria Type 1 in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations